Toni Choueiri M.D. Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute/Brigham and Womens Hospital and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School Discusses Novel Oral HIF-2 Alpha Inhibitor PT2977. At The Fourteenth European International Kidney Cancer Symposium on Mar 29, 2019.
Novel Oral HIF-2 Alpha Inhibitor PT2977
